Post-earnings recap
Reported
Thu, Jul 25, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
United Therapeutics reported a strong EPS performance, significantly exceeding expectations. The stock reacted positively, rising 1.73% after the announcement. However, the lack of revenue data and guidance may leave investors cautious about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.11 | N/A | +111.28% |
| Revenue | N/A | N/A | N/A |
Management highlighted the strong earnings performance, particularly in EPS. They emphasized their commitment to ongoing strategic initiatives without offering specific revenue guidance.
Management expressed satisfaction with the strong EPS performance.
The company remains focused on its strategic initiatives.
No specific revenue guidance was provided, but the outlook remains positive.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—